CIK 0000748592 · Non-accelerated filer<br>Smaller reporting company
Ernexa Therapeutics Inc.
Sign in to watch- Ticker
- ERNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 311103425
- Phone
- (617) 798-6700
- Business address
- 1035 CAMBRIDGE STREET, SUITE 18A, CAMBRIDGE, MA, 02141
- Former names
- Eterna Therapeutics Inc., Brooklyn ImmunoTherapeutics, Inc., NTN BUZZTIME INC, NTN COMMUNICATIONS INC
Securities
- ERNA Common Stock Nasdaq
- ERNAW Warrants Nasdaq
- SC 13D/A Stake Beneficial Ownership Report
- D Other Notice of Sales of Unregistered Securities
- D Other Notice of Sales of Unregistered Securities
- SC 13G/A Stake Amended Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale
- 4 Derivatives Options or other derivatives
- 8-K Event Material agreement
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 4 Shares withheld for taxes Vice President of Finance gave up 179 shares (to pay taxes)
- 8-K Event Shareholder vote results
- 10-Q Report Quarterly Report
- DEFA14A Proxy Proxy Materials
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 8-K Event Executive or director change
Page 10 of 77 · 1,525 filings